Skip to content
Artificall
  • Home
  • Company Analyses
  • Indicators
  • Learn
  • About
  • 0
  • Toggle website search
0
Menu Close

Drug Manufacturers – General

Johnson & Johnson: Evaluating Growth and Risks in 2025

Read more about the article Johnson & Johnson: Evaluating Growth and Risks in 2025
  • Post author:Vivien Schmitt
  • Post published:6 December 2025
  • Post category:Company Analysis

Imagine a world where the latest medical innovations are just a prescription away, transforming lives and extending healthspan. Johnson & Johnson epitomizes this vision, standing tall as a powerhouse in…

Continue ReadingJohnson & Johnson: Evaluating Growth and Risks in 2025

Amgen vs Intuitive Surgical: Which Stock Should You Buy?

Read more about the article Amgen vs Intuitive Surgical: Which Stock Should You Buy?
  • Post author:Vivien Schmitt
  • Post published:30 November 2025
  • Post category:Company Comparisons

In the ever-evolving landscape of healthcare, Amgen Inc. and Intuitive Surgical, Inc. stand out as formidable players, each innovating within their respective niches. Amgen is a leader in biopharmaceuticals, focusing…

Continue ReadingAmgen vs Intuitive Surgical: Which Stock Should You Buy?

Amgen vs Gilead: Which Stock Should You Choose?

Read more about the article Amgen vs Gilead: Which Stock Should You Choose?
  • Post author:Vivien Schmitt
  • Post published:17 November 2025
  • Post category:Company Comparisons

In the dynamic landscape of healthcare, two prominent players, Amgen Inc. (AMGN) and Gilead Sciences, Inc. (GILD), stand out in the drug manufacturing industry. Both companies leverage innovation to address…

Continue ReadingAmgen vs Gilead: Which Stock Should You Choose?

AstraZeneca vs Gilead: Which Stock Is a Better Buy?

Read more about the article AstraZeneca vs Gilead: Which Stock Is a Better Buy?
  • Post author:Vivien Schmitt
  • Post published:17 November 2025
  • Post category:Company Comparisons

In the rapidly evolving biopharmaceutical sector, AstraZeneca PLC (AZN) and Gilead Sciences, Inc. (GILD) stand out as prominent players. Both companies operate in the drug manufacturing space and have a…

Continue ReadingAstraZeneca vs Gilead: Which Stock Is a Better Buy?

AstraZeneca vs Amgen: Which Is the Better Investment?

Read more about the article AstraZeneca vs Amgen: Which Is the Better Investment?
  • Post author:Vivien Schmitt
  • Post published:17 November 2025
  • Post category:Company Comparisons

In the dynamic world of healthcare, AstraZeneca PLC (AZN) and Amgen Inc. (AMGN) stand out as titans within the drug manufacturing sector. Both companies are heavily involved in innovative therapeutic…

Continue ReadingAstraZeneca vs Amgen: Which Is the Better Investment?

Biogen: Navigating Opportunities and Risks in 2025

Read more about the article Biogen: Navigating Opportunities and Risks in 2025
  • Post author:Vivien Schmitt
  • Post published:16 November 2025
  • Post category:Company Analysis

Biogen Inc. transforms the landscape of healthcare by pioneering innovative therapies for neurological and neurodegenerative diseases, directly impacting the lives of millions. With a robust portfolio that includes treatments for…

Continue ReadingBiogen: Navigating Opportunities and Risks in 2025

Gilead Sciences: Navigating Opportunities and Risks in 2025

Read more about the article Gilead Sciences: Navigating Opportunities and Risks in 2025
  • Post author:Vivien Schmitt
  • Post published:16 November 2025
  • Post category:Company Analysis

Gilead Sciences, Inc. is not just a player in the biopharmaceutical sector; it is a transformative force that revolutionizes how we approach some of the world's most pressing health challenges.…

Continue ReadingGilead Sciences: Navigating Opportunities and Risks in 2025

Amgen 2025: Assessing Growth Potential Amidst Market Shifts

Read more about the article Amgen 2025: Assessing Growth Potential Amidst Market Shifts
  • Post author:Vivien Schmitt
  • Post published:16 November 2025
  • Post category:Company Analysis

Amgen Inc. is revolutionizing healthcare by delivering groundbreaking therapies that enhance lives and redefine treatment standards. As a powerhouse in the biotechnology sector, its innovative portfolio includes transformative medications for…

Continue ReadingAmgen 2025: Assessing Growth Potential Amidst Market Shifts

AstraZeneca: Assessing Risks and Opportunities in 2025

Read more about the article AstraZeneca: Assessing Risks and Opportunities in 2025
  • Post author:Vivien Schmitt
  • Post published:16 November 2025
  • Post category:Company Analysis

AstraZeneca PLC is at the forefront of transforming healthcare, with its groundbreaking therapies touching millions of lives globally. This biopharmaceutical giant excels in the discovery and commercialization of innovative medicines,…

Continue ReadingAstraZeneca: Assessing Risks and Opportunities in 2025

Get Your Free Indicator

The Range Breaker indicator will help you trade the range breakouts on Prorealtime:

Range Breakout Indicator Prorealtime

Recent Posts

  • Johnson & Johnson: Evaluating Growth and Risks in 2025
  • OpenAI’s Code Red: Navigating Competitive Pressures in AI Market
  • Uranium Energy vs Energy Fuels: Which Is the Better Buy?
  • American Express vs Visa: Which Stock Is a Better Buy?
  • Xylem vs American Water: Which Stock Should You Choose?
  • Amgen vs Intuitive Surgical: Which Stock Should You Buy?
  • Wix vs Shopify: Which Stock Should You Choose?
  • ESAB vs IPG: Which Stock Offers Better Value?
  • Lincoln Electric vs IPG Photonics: Which Stock to Choose?
  • Lincoln Electric vs ESAB: Which Is the Better Investment?

Indicators for Prorealtime

Ultimate Breaker Indicator for Prorealtime
Advanced Elliott Wave Indicator Prorealtime
Bullish Harmonics Indicator Prorealtime
Advanced Wolfe Wave Indicator Prorealtime
TrendLines Breaker Indicator for Prorealtime
Stock Breakout Indicator & Screener for Prorealtime
CandleSticks Indicator Prorealtime
Golden Cross Indicator for Prorealtime
Chart Figure Breakout Indicator Prorealtime

Join me

Facebook
Prorealcode
Twitter X
LinkedIn

Navigation

  • Home
  • Company Analyses
  • Indicators
  • Learn
  • About

Company Analyses

  • Nasdaq-100

  • Artificial Intelligence

  • Robotics

  • Quantum Computing

  • Industrial Automation

  • Uranium

  • Market News

Personal space

  • Products
  • Account details
  • Downloads
  • Orders
  • Lost password
  • Indicator Documentation

Company information

MONSIEUR VIVIEN SCHMITT
SIREN : 891 823 163
SIRET : 891 823 163 00011
TVA : FR78891823163
Country : France

Follow us

Facebook
Twitter X
LinkedIn
Prorealcode
© 2025 - Artificall.com. All Rights Reserved
Close Menu
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

Disclaimer

Artificall provides educational content, custom indicators, screeners, and trading systems intended for informational purposes only. We are not registered financial advisors, and the tools and strategies shared on this website do not constitute investment advice or recommendations to buy or sell any financial instrument. Trading in financial markets involves significant risk and may not be suitable for all investors. Past performance of any trading system, indicator, or strategy is not indicative of future results. You should carefully consider your investment objectives, level of experience, and risk appetite before engaging in trading. Artificall does not accept any liability for loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from the use of or reliance on any information, tools, or products provided through this site. All users are solely responsible for their own trading decisions. We strongly recommend consulting with a licensed financial advisor before making any financial decisions. By using this website and its resources, you agree to these terms and acknowledge that you understand the inherent risks of trading.

Terms and Conditions

×

Cart